Beijing Beilu Pharmaceutical Capital Reinvestment Ratio

Latest as of September 2025: 0.78x

Beijing Beilu Pharmaceutical capital reinvestment ratio. Beijing Beilu Pharmaceutical (300016) has a Capital Reinvestment Ratio of 0.78x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥74.66 Million) in capital expenditures (CN¥57.96 Million). See 300016 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.78x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥74.66 Million
CNY

Capital Expenditures

CN¥57.96 Million
CNY

Data as of

Sep 2025
Most recent filing

Capital Reinvestment Ratio of Beijing Beilu Pharmaceutical (2006–2024)

Capital reinvestment ratio of Beijing Beilu Pharmaceutical from 2006 to 2024. This chart tracks Beijing Beilu Pharmaceutical's Capital Reinvestment Ratio across 18 annual periods. See 300016 financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Beijing Beilu Pharmaceutical Capital Reinvestment Ratio by Year (2006–2024)

Beijing Beilu Pharmaceutical capital reinvestment ratio by year from 2006 to 2024. For the full cash flow conversion analysis, see Beijing Beilu Pharmaceutical operating cash flow efficiency.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 0.62x CN¥163.02 Million CN¥101.39 Million ▼ -74.9%
2023 2.47x CN¥58.46 Million CN¥144.61 Million ▲ +207.6%
2022 0.80x CN¥127.81 Million CN¥102.78 Million ▼ -40.8%
2021 1.36x CN¥108.73 Million CN¥147.76 Million ▲ +39.0%
2020 0.98x CN¥176.00 Million CN¥172.10 Million ▲ +338.3%
2019 0.22x CN¥156.81 Million CN¥34.99 Million ▼ -27.5%
2018 0.31x CN¥175.75 Million CN¥54.06 Million ▼ -19.0%
2017 0.38x CN¥144.92 Million CN¥55.00 Million ▼ -34.6%
2016 0.58x CN¥76.17 Million CN¥44.21 Million ▼ -32.2%
2015 0.86x CN¥80.85 Million CN¥69.23 Million ▼ -16.1%
2014 1.02x CN¥42.11 Million CN¥42.99 Million ▲ +19.0%
2013 0.86x CN¥41.37 Million CN¥35.48 Million ▼ -69.1%
2012 2.78x CN¥22.86 Million CN¥63.47 Million ▲ +298.4%
2011 0.70x CN¥45.73 Million CN¥31.87 Million ▼ -49.5%
2010 1.38x CN¥37.51 Million CN¥51.77 Million ▲ +1403.5%
2009 0.09x CN¥57.91 Million CN¥5.32 Million ▲ +393.1%
2007 0.02x CN¥12.28 Million CN¥228.50K ▼ -75.7%
2006 0.08x CN¥19.65 Million CN¥1.51 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow